State Street’s Tenax Therapeutics TENX Stock Holding History

State Street’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.43M	Buy	510,814 +481,824	+1,662%	+$6.16M	﹤0.01%	2836
2026 Q1	$464K	Buy	+28,990	New	+$392K	﹤0.01%	3674
2024 Q1	–	Sell	-1,188	Closed	-$26.1K	–	4401
2023 Q4	$26.1K	Sell	1,188 -1	-0.1%	-$24	﹤0.01%	4314
2023 Q3	$28K	Hold	1,189	–	–	﹤0.01%	4398
2023 Q2	$28.5K	Hold	1,189	–	–	﹤0.01%	4541
2023 Q1	$44.2K	Buy	1,189 +1,102	+1,267%	+$115K	﹤0.01%	4532
2022 Q4	$15.3K	Hold	87	–	–	﹤0.01%	4767
2022 Q3	$24K	Hold	87	–	–	﹤0.01%	4802
2022 Q2	$42K	Hold	87	–	–	﹤0.01%	4755
2022 Q1	$112K	Buy	87 +2	+2%	+$2.23K	﹤0.01%	4611
2021 Q4	$142K	Hold	85	–	–	﹤0.01%	4481
2021 Q3	$241K	Hold	85	–	–	﹤0.01%	4291
2021 Q2	$296K	Buy	+85	New	+$269K	﹤0.01%	4057

Other funds holding TENX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street's TENX Position: Q2 2026 in Review

State Street increased its Tenax Therapeutics (TENX) stake by 1,662% in Q2 2026, buying an estimated $6.16M and bringing the position to 510,814 shares worth $7.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

State Street first reported a position in TENX in Q2 2021 and has held it in 13 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

State Street held 510,814 shares of Tenax Therapeutics worth $7.43M as of Q2 2026.
State Street bought 481,824 Tenax Therapeutics shares in Q2 2026, an estimated $6.16M.
Tenax Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2836 holding.
State Street first reported a position in Tenax Therapeutics in Q2 2021 and has held it in 13 quarters since.
111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.